Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
Seminar: Policies around Access to Medicines & Human RightsNews
Watch the presentations of the "Sustainability, Health Systems and Human Rights" at the Seminar on Policies of Access to Medicines and Human Rights.
Price of HIV Drug Atripla Set to DropNews
Almost 3000 more people living with HIV set to get life-saving treatment in Ukraine.
Want to Improve Access to ARVs?News
Sign up for your chance to learn how to challenge intellectual property barriers, that impede access to affordable medicines.
Argentina civil society launch campaign “Big Pharma – Drop the case!”News
Fundación Grupo Efecto Positivo (GEP), with regional partners, launches a campaign to demand that pharmaceutical companies drop their case which...
Civil Society Advocates for Intellectual Property Law Reform in UkraineNews
The All-Ukrainian Network of People Living with HIV (Network) advocate for change of law to improve access to medicines, in...
Going to AIDS 2016? Let us know how you feel about your HIV treatment?News
Happy or sad about your HIV treatment, add your picture at the Treatment Networking Zone to support our campaign to end the injustice of treatment inequality.
Compulsory licensing to increase access to antiretroviral drugsNews
The Network organizes Roundable to explore Compulsory Licensing for Ukraine. On 22 June 2016, the All-Ukrainian Network of People Living...
High price of lopinavir/ritonavir challenged in UkraineNews
All-Ukrainian PLHIV Network challenges patent, and exclusive right to manufacture lopinavir/ritonavir.
Civil society cautions Thai Ministers about Trans-Pacific Partnership AgreementNews
AIDS Access Foundation, FTA Watch and other civil society organizations caution Thai government against the Trans-Pacific Partnership Agreement. On 31...
A generic version of dolutegravir will be made available in Morocco: A major victory for ITPC-MENANews
After several months of intense advocacy by treatment activists, ViiV Healthcare has extended its dolutegravir license to Morocco, meaning more...